Naproxen
- Product NDC
- 42291-630
- 11-digit product format
- 422910630
- Labeler code
- 42291
- Product ID
- 42291-630_c83295f4-d998-4ade-a186-ed91ced4abe0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- AvKARE, Inc.
- Application
- ANDA091432
- Marketing category
- ANDA
- Marketing start
- 2013-10-24
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-630-01 | 42291063001 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (42291-630-01) | 2013-10-24 | 0000-00-00 | No | No | Current |